Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Iosif Pediaditakis(Forma Therapeutics (United States)), Katia Karalis(Regeneron (United States))
Cited by 220
Related Papers
Reproducing human and cross-species drug toxicities using a Liver-Chip
|Science Translational Medicine|2019|478